WEX Pharmaceuticals Inc.
WEX Pharmaceuticals Inc. (WEX Pharmaceuticals) is a publicly listed company engaged in the discovery, development, manufacturing and commercialization of new class therapeutics for the treatment of acute and chronic pain. WEX is primarily focused on developing drug products for pain management. The product platform of WEX Pharmaceuticals, Tetrodotoxin (TTX) is a sodium channel blocker, which is useful for the development of the product portfolio of company including: TECTIN-Analgesia, TETRODIN-Detoxification and TOCUDIN-Anaesthesia. WEX Pharmaceuticals is specialized in the development, purification and manufacturing of TTX. WEX has two additional offices, WEX Medical Limited, (Hong Kong) and Nanning Maple Leaf Pharmaceutical Co., Ltd. (China)- the R&D and manufacturing facility of WEX Pharmaceuticals. The company is headquartered at Vancouver in British Columbia, Canada.